The impact of glucocorticoids on b-amyloid
The impact of glucocorticoids on b-amyloid (1-42) (Ab ) and NMDA-induced neurodegeneration was investigated in vivo. Ab or NMDA was injected into the cholinergic magnocellular nucleus basalis in adrenalectomized (ADX) rats, ADX rats supplemented with 25%, 100%, 2×100% corticosterone pellets, or sham-ADX controls. Ab
(1-42) -or NMDA-induced damage of cholinergic nucleus basalis neurones was assessed by quantitative acetylcholinesterase histochemistry. Plasma concentrations of corticosterone and cholinergic fibre loss after Ab or NMDA injection showed a clear U-shaped dose-response relationship. ADX and subsequent loss of serum corticosterone potentiated both the Ab and NMDA-induced neurodegeneration. ADX+25% corticosterone resulted in a 10-90 nM plasma corticosterone concentration, which significantly attenuated the Ab and NMDA neurotoxicity. ADX+100% corticosterone (corticosterone concentrations of 110-270 nM) potently decreased both Ab
(1-42) -and NMDA-induced neurotoxic brain damage. In contrast, high corticosterone concentrations of 310-650 nM potentiated Ab -and NMDA-triggered neurodegeneration. In conclusion, chronic low or high corticosterone concentrations increase the vulnerability of cholinergic cells to neurotoxic insult, while slightly elevated corticosterone levels protect against neurotoxic injury. Enhanced neurotoxicity of NMDA in the presence of high concentrations of specific glucocorticoid receptor agonists suggests that the corticosterone effects are mediated by glucocorticoid receptors.
Glucocorticoids (cortisol in primates, corticosterone in rat)
Both neuroprotective and neurodegenerative effects of glucocorticoids have been reported (4, 8) . Lack of glucocorticoids are secreted from the adrenal cortex upon activation of the hypothalamic-pituitary-adrenal axis as a response to stressful as a result of adrenalectomy (ADX ) induces degeneration of dentate gyrus neurones in the hippocampus (9, 10) . On the environmental stimuli. Glucocorticoids readily pass the blood-brain barrier and thus have direct access to neural other hand, kainic acid-induced hippocampal damage was shown to be decreased following ADX (11) . Increased susceptissue where they bind with high affinity to intracellular mineralocorticoid receptors and with low affinity to glucocorttibility of hippocampal neurones to metabolic or excitotoxic insults was observed after exposure to high concentrations of icoid receptors in both neurones and glia, and influence cellular homeostatic mechanisms (1-3). Glucocorticoids are glucocorticoids (7, 12) . Corticosterone can enhance cell death triggered by oxidative stress (4) and exacerbate degeneration of particular interest since it has become evident that these hormones can modulate neurodegenerative processes that of cholinergic nerve fibres after exposure to cholinotoxins (13). Stress-induced chronic elevations of corticosterone have occur in hypoxia and ischemia, stroke, neurotoxic trauma, seizures, ageing and Alzheimer's disease (4) (5) (6) (7) .
been found to cause dendritic atrophy of rat hippocampal on Ab-and NMDA-induced neuronal damage in the MBN, After all Ab or NMDA injections the rats survived for 11 days before which mimicks neuropathological aspects of Alzheimer's disbeing killed for histological processing.
ease and stroke, respectively. The Ab-and NMDA-neurotox-
Determination of plasma corticosterone concentrations
icity was studied in rats that were pretreated by ADX or by radioimmunoassay without extraction as described previously (30) . Briefly, the antiserum was raised in rabbit against corticosteronecarboxymethyloxime-BSA. 125I-labelled corticosterone-carboxymethyloximetyrosine-methyl ester was used as the tracer. The interference of plasma
Materials and methods
transcortin was eliminated by inactivating transcortin at low pH. The sensitivAnimals ity of the assay was 0.1 pmol. Intra-and interassay variations were 6.4% and 23.8%, respectively. Young adult male Wistar rats weighing 300-350 g were used for all experiments. The rats were group-housed at 24°C and 55-65% humidity in a Tissue preparation light5dark cycle (12 h : 12 h) with lights on at 07.30 h. Rats had access to The rats were killed by an overdose of sodium pentobarbital injected i.p. The standard rat chow and tap water ad lib. All experimental procedures complied brains were fixed by transcardial perfusion with 300 ml ice-cold fixative with the NIH Guide to the Care and Use of Laboratory Animals (1985) as composed of 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4) well as the guidelines of the Animal Care Committee of the University of at 27 ml/min, which was preceded by a short pre-rinse of heparinized saline. Groningen in accordance with the European Community Council Directive
The brains were removed from the skull and postfixed for 3 h in the same 86/609.
fixative, followed by 48 h storage at 4°C in PBS with 30% sucrose for Ab peptide synthesis cryoprotection. Subsequently, the brains were coronally sectioned on a cryostat microtome at thickness of 20 mm. Brain sections were postfixed by Ab (1-42) was synthesized with amide at the C-terminal by a solid-phase immersion in 2.5% glutaraldehyde in 0.01 M PBS overnight before technique involving Boc chemistry as previously described in detail (28) .
histochemistry. Briefly, peptide chains were elongated on 4-methylbenzhydrylamine (MBHA) resin (0.6-0.8 mmol/g) and the syntheses were carried out on an ABI 430 A Acetylcholinesterase histochemistry (Biolytic Lab Performance, Inc. Fremont, CA, USA) automated peptide synthesizer. Couplings were performed with dicyclohexylcarbodiimide with Sections were stained for acetylcholinesterase (AChE ) using a silver nitrateintensification procedure (31) . Briefly, the sections were incubated for 2 h at the exception of asparagine, which was incorporated in OHBt-ester form. The Boc group was removed by treatment with 50% trifluoroacetic acid in room temperature (RT ) in a sodium-acetate-buffered solution (0.1 M, pH 6), containing acetylthiocholine iodide (25 mg/50 ml medium), sodium citrate decrease of 42.1±1.8% of cholinergic fibres, while injection (0.1 M ), copper sulphate (0.03 M ) and potassium ferricyanide (5 mM (32)), representing the densest cholinergic innervation from the damaged MBN division (22). After background substraction and grey-scale threshold determination, the surface area of skeletonized AChE-positive fibres was computed in each parietal cortical section by using a 599-nm emission filter. The relative value of fibre reduction was calculated in pre-established quadrants as the percentage difference between the surface area density at lesioned and contralateral sides of the brain.
Statistical analysis
The relationship between AChE fibre loss and corticosterone concentration was determined by nonlinear regression analysis followed by residual analysis. Data of AChE fibre loss were expressed as means±SEM. Analysis of variance followed by Student-Keuls-Newman comparison was used for group differences (P<0.05).
Results
In the ADX rats the corticosterone concentration at the end of the experiments was in a range of 0-8 nM. Adrenalectomy and 25% corticosterone pellet implantation, and ADX with 100% corticosterone pellet implants resulted in concentrations of plasma corticosterone of 20-90 nM and 110-270 nM, respectively. In the ADX+2×100% CORT rats plasma concentrations of corticosterone reached levels of 310-650 nM. In the cannulated SHAM-ADX rats according to our standard experimental surgery conditions, the basal corticosterone concentrations was in the same range as that of ADX+25% CORT rats. SHAM-ADX rats receiving a vehicle injection of ultrapure water or PBS into the MBN showed a limited damage to the MBN, with an average reduction of 3.5±1.5% AChE positive fibres in the ipsilateral somatosensory cortex, similar to previous studies. In the SHAM-ADX control rats, injection of 60 nmol NMDA into the MBN resulted in a profound the concentration range of 20-90 nM, since the fibre loss in the ADX-25% CORT group did not significantly differ which case cholinergic fibre loss was 67.1±1.7% and 23.5±1.3%, respectively ( Figs 1, 2, 3,, 4,) . This correfrom the reduction in the SHAM-ADX group (40.9±2.33%, Fig. 1 ). However, corticosterone concentrations in the sponds to an increase of the excitotoxic damage of 59% and 27% for the NMDA-and the Ab-induced lesions, respectively. ADX-25% CORT group had a more dramatic protective effect on Ab toxicity and significantly decreased Ab-induced The increased vulnerability to NMDA neurotoxicity after ADX was clearly prevented by corticosterone replacement in AChE fibre loss compared to the Ab-induced damage in the SHAM-ADX operated rats (8.4±1.65%, Figs 2, 4), which represents a neuroprotective effect of 54%. Interestingly, the effects of the ADX-25% CORT group in both the Ab and NMDA lesion experiments revealed an apparent minor dichotomy. The three lowest corticosterone values (40 and 33 nM in the NMDA and Ab experiments, respectively) corresponded with an initial reduction of injury, while the three highest corticosterone values (averages of 76 and 81 nM in the NMDA and Ab experiments, respectively) were followed by a slightly higher degree of injury (arrows in insets in Figs  1, 2 ). Administration of corticosterone by a 100% corticosterone pellet in the ADX animals, which yielded plasma concentrations of 110-270 nM of corticosterone, potently and significantly attenuated cholinergic neuronal damage after both NMDA and Ab deposits in the MBN. In these experimental groups the cortical fibre reductions after NMDA or Ab injections were 18.77±2.9% and 3.87±1.71%, which can be expressed as a neuroprotection of 55% against NMDA lesion, and 79% against Ab infusion.
This neuroprotective pattern of midrange corticosterone concentrations was reversed by implants of 2×100% pellets. In these experimental conditions with plasma corticosterone concentrations of 310-650 nM the NMDA lesion of the MBN resulted in a loss of 69.5±4.93% cholinergic fibres, which is a significant enhancement of 65% of the NMDA damage in SHAM-ADX rats. The presence of very high corticosterone concentrations evoked a similar effect in the Ab-induced MBN damage and yielded a loss of cholinergic cortical fibres of 17.11±3.1%. This was in striking contrast to the midrange corticosterone effects but was not different from the degree of injury after Ab injection in the SHAM-ADX control rats (Fig. 2) .
The i.p. injection of dexamethasone and RU 28362 1 h before the intraparenchymal injection of NMDA in the MBN significantly potentiated the NMDA-induced cholinergic cell damage and concomitant cortical cholinergic fibre loss compared to the values after NMDA and vehicle injection (39.7±2.0%). The dexamethasone and RU28362 pretreatthis effect was dependent on the plasma corticosterone concentration and could vary from enhancement of neurotoxic ments resulted in a AChE fibre loss of 61.3±2.9% and 64.3±2.1% (Fig. 5) , which is an enhancement of excitotoxic mechanisms to neuroprotection. Graphically expressed, the dose-response relationship between the plasma corticosterone injury of 45% and 52%, respectively. concentration and neurotoxicity exhibits a 'U'-shaped curve. It appeared that a very low corticosterone range as in ADX Discussion animals potentiated both the Ab-or the NMDA-induced cholinotoxicity in the MBN, while this potentiation was The present data provide in-vivo experimental evidence that corticosterone exerts a powerful effect on Ab-or NMDAabsent at a basal corticosterone range of 20-90 nM.
Moderately elevated corticosterone concentrations of 110-induced injury to cholinergic neurones of the nucleus basalis complex and their cortical projection fibres. The nature of 270 nM significantly and strongly reduced excitotoxic injury, F. 4. Photomicrographs of AChE-positive fibres in the parietal cortex at the side of the brain ipsilateral to the injection of Ab in the nucleus basalis, in rats after removal of the adrenals (ADX ) (), in ADX rats with 25% corticosterone (), ADX and 100% corticosterone (), and ADX with 2×100% corticosterone pellet implantations ( ). White bars in () indicate the position of layer V of the cortex that was measured for fibre densities by image analysis. Scale bar in ()=100 mm for all four panels.
whereas this neuroprotective effect was reversed to an increase The mechanisms underlying the observed effects of corticosterone on the induced neurotoxicity likely involve a number of neurotoxic damage evoked by Ab or NMDA at high corticosterone concentrations in the 'stress' level range of of physiological and cellular components. This is not only suggested by the impressive impact of the hormone treatment 310-650 nM. The finding that such increased damage after NMDA injections was mimicked by application of the glucobut also by the U-shape of the dose-response relation, which is not uncommon for actions of glucocorticoids on neuronal corticoid receptor agonists dexamethasone or RU28362 indicates that the corticosterone effects are mediated by tissue (34, 35) . In general, corticosterone profoundly affects the excitability of nerve cells and ionic conductances (34, glucocorticoid receptors. These data corroborate the findings of Cintra et al. (33) who reported the presence of glucocort-36), regulates neuronal energy supply and metabolism (37, 38) , and influences [Ca2+] i homeostasis (39) (40) (41) all of which icoid receptors in nucleus basalis neurones.
This mechanism may also apply to Ab-induced neurodegeneration in the MBN in the absence of corticosterone. Ab can potentiate glutamate toxicity (46, 47) by the generation of transmembrane Ca2+ fluxes, whereas a role for NMDA receptors was postulated in Ab-induced Ca2+-entry, as Ab toxicity was significantly attenuated in the presence of NMDA receptor antagonists (24, 48, 49) . Ab peptides inhibit glutamate uptake by astrocytes (50) and trigger a rise in extracellular glutamate (28) which in the absence of corticosterone can increase Ab-induced excitotoxicity via elevated [Ca2+] i and subsequent neuronal cell death.
Elevated concentrations of corticosterone (20-90 nM and 110-270 nM): possible neuroprotective mechanism
The detrimental effects of ADX on excitotoxic brain damage in the present experimental set-up were effectively compensated by a slight elevation of plasma corticosterone that resulted from 25% corticosterone pellet implantations. In these cases with corticosterone concentrations from 20 to 90 nM the experimental neuronal damage was either equal to or less than the injury level after NMDA or Ab injections in SHAM-ADX rats, which demonstrates that low concentrations of corticosterone are essential for neuronal survival. notably of hippocampal cells (18, 34, 35) . Low concentrations of corticosterone result in a small voltage-gated Ca2+ current and a steady ionic flow through amino acid receptors, mediated by corticosterone effects on mineralocorticoid receptors are essential for neuronal functioning. In the present investi- (36) . In contrast, at elevated corticosterone concentrations gation regarding the impact of corticosterone on experimental in a physiological range which activates glucocorticoid recepneurodegenerative processes, three conditions could be distintors, the Ca2+ currents are relatively large and the amino guished associated with very low, intermediate and very high acid receptor-mediated responses reduced (36, 39) . This larger corticosterone concentrations that each characteristically corticosterone-evoked Ca2+ current was demonstrated in influenced neurotoxic processes.
hippocampal pyramidal cells to enlarge the afterhyperpolarization, which attenuates the sensitivity of these cells for excitatory amino acid stimulation. Since nucleus basalis neurAbsence or very low corticosterone levels and ones are endowed with glucocorticoid receptors, elevated neurodegeneration corticosterone concentrations may thus render the MBN The present data clearly indicate that absence of corticosneurones less sensitive to excitotoxic input (18, 34, 40) . terone or very low corticosterone concentrations aggravate Interestingly, the lower physiological range of corticosterone experimental neuronal damage after the NMDA or Ab concentrations significantly attenuated the Ab-induced neurinjections. There is ample evidence for increased sensitivity onal injury. The reason for this is not clear but we anticipate of neurones in the absence of corticosterone. Previous reports that Ab toxicity may be influenced not only by corticosterone have shown that removal of the adrenal glands results in but also by additional adrenal hormones. In this respect degenerative changes in the dentate gyrus of the hippocampus ADX and corticosterone suppletion leads to a sustained (9, 10, 42) . The mechanism of neurodegeneration under very steady-state corticosterone concentration and will influence low concentrations of corticosterone is unclear but a critical neuronal viability different from the characteristic circadian role of [Ca2+] i may be implicated. The most prominent effect rhythmicity of basal corticosterone in adrenally intact of ADX appears to be that the voltage-gated Ca2+ currents conditions. display a very large amplitude (40) , with a concurrent small Ca2+-dependent K+ conductance (18) . Furthermore this Exposure to high (310-650 nM) glucocorticoid levels: effect may be chronic since absence of corticosterone increases enhanced neurodegeneration the relative numbers of -type Ca2+ channels (43) . Since NMDA injection increases the Ca2+ influx via NMDA In contrast to the neuroprotective effects of midrange corticoreceptor channels and secondarily via voltage-gated Ca2+ sterone concentrations, high levels of corticosterone in ADX channels (44, 45) this process can synergistically act on the rats reversed this process and enhanced the neurotoxicity of ADX-induced rise of [Ca2+] i thereby increasing the probabilAb, and in particular of NMDA. A high concentration of glucocorticoids in itself can lead to neurodegeneration and ity of neuronal cell death. 12 Sapolsky RM. A mechanism for glucocorticoid toxicity in the hippocamcell shrinkage (51, 52) . Prolonged elevation of corticosterone pus: increased neuroneal vulnerability to metabolic insults. J Neurosci was shown to increase the vulnerability of nerve cells to 1985; 5: 1227-1231. neurodegenerative processes in ageing, cerebral ischemia and 13 Hortnagl H, Berger ML, Havelec L, Hornykiewicz O. Role of glucocortpossibly other neurodegenerative diseases (6, 7, 15, 35) . icoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridium (AF64A). J Neurosci 1993; 13: 2939-2945.
The main current hypothesis to explain the high glucocort-
